Managing bipolar disorder: Misdiagnosis and quality of life

American Journal of Managed Care

Volumn 11, Issue SUPPL. 9, 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; PLACEBO; QUETIAPINE;

ABSENTEEISM; ALCOHOL ABUSE; ALCOHOLISM; ANAMNESIS; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; EATING DISORDER; EDITORIAL; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT CARE; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REGISTER; SOCIAL PHOBIA; SUICIDE ATTEMPT; SYMPTOM; UNEMPLOYMENT; WORK DISABILITY;

BIPOLAR DISORDER; COST OF ILLNESS; DIAGNOSTIC ERRORS; HUMANS; QUALITY OF LIFE;

EID: 27544471344     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (35)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol. 1995;30:279-292.
3. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59 (suppl 1):S5-S30.
4. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders, and hypomania. J Affect Disord. 2003;73:133-146.
5. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990.
6. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry. 1995;152:379-384.
7. Dion GL, Tohen M, Anthony WA, Waternaux CS. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry. 1988;39:652-657.
8. Keck PE, McElroy SL, Strakowski SM, et al. Outcome and comorbidity in first- compared with multiple-episode mania. J Nerv Ment Dis. 1995;183:320-324.
9. Post RM, Susan R, Weiss B. Sensitization, kindling, and carbamazepine: an update on their implications for the course of affective illness. Pharmacopsychiatry. 1992;25:41-43.
10. Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
11. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin. 2004;20:139-154.
12. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness-1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:213-219.
13. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
14. Chen YW, Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry. 1995;152:280-282.
15. Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59:57-64.
16. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3:181-188.
17. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420-426.
18. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68:1-23.
19. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67:1-8.
20. McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):35-44.
21. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174.
22. Olfson M, Fireman B, Weissman MM, et al. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 1997;154:1734-1740.
23. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294.
24. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999;52:135-144.
25. Angst J, Gamma A, Lewinsohn P. The evolving epidemiology of bipolar disorder. World Psychiatry. 2002;1:146-148.
26. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156:1264-1266.
27. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry. 2001;62:565-569.
28. Bolge SC, Rajagopalan K. Quality of life: mis-diagnosed bipolar disorder vs depression on bipolar disorder. Presented at the Fourth European Stanley Conference, September 23-25, 2005; Aarhus, Denmark.
29. Li J, McCombs JS, Stimmel GL. Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord. 2002;71:131-139.
30. McCombs JS, Thiebaud P, Shi L. Impact of unrecognized bipolar disorders in patients treated with antidepressant medications [abstract]. Value Health. 2003;6:352.
31. Cooke RG, Robb JC, Young LT, Joffe RT. Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-ITEM short form (SF-20). J Affect Disord. 1996;39:93-97.
32. US Department of Health, Education, and Welfare. Medical practice project: a state-of-the-science report for the office of the Science Secretary for the US Department of Health, Education, and Welfare. Baltimore, Md: Policy Research; 1979.
33. Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord. 2004;81:123-131.
34. Namjoshi MA, Buesching DP. A review of the health-related quality of life literature in bipolar disorder. Qual Life Res. 2001;10:105-115.
35. Endicott J, Rajagopalan K, Minkwitz M. Efficacy of quetiapine in improving quality of life in patients with bipolar depression. Presented at the Academy of Managed Care Pharmacy 17th Annual Meeting & Showcase, April 20-23, 2005; Denver, Colo.